Medifast Inc

NYSE: MED
$18.30
+$0.14 (+0.8%)
Closing Price on November 21, 2024

MED Stock Chart and Intraday Price

MED Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector MANUFACTURING
Industry MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS
Address 11445 CRONHILL DRIVE, OWINGS MILLS, MD, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 440.62M USD
Shares Outstanding 10,895,600
Medartis Holding AG specializes in creating advanced medical devices for bone fracture surgery and cranio-maxillofacial procedures. With a focus on innovation, they offer a wide range of osteosynthesis instruments under the APTUS and MODUS brands, catering to various parts of the body including the hand, wrist, elbow, and more. Founded in 1997 and based in Basel, Switzerland, Medartis is dedicated to supporting surgeons, hospitals, and medical centers around the globe with high-quality implant solutions.

MED Articles

With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
 The inflationary environment over the past few years has constricted consumer buying power, resulting in supplementary income requirements by many. For those who cannot augment their paychecks with...
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and...
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and...
Monday's top analyst upgrades and downgrades included Altice USA, Arista Networks, Block, Cardinal Health, ConocoPhillips, Datadog, GoodRx, Monster Beverage, PepsiCo, Spirit AeroSystems, Twilio and...